Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients

dc.contributor.author	Macías Sánchez, Juan
dc.contributor.author	Neukam, Karin
dc.contributor.author	Mallolas Masferrer, Josep
dc.contributor.author	Cartón Sánchez, José Antonio
dc.date.accessioned	2013-01-30T09:57:56Z
dc.date.available	2013-01-30T09:57:56Z
dc.date.issued	2012
dc.identifier.citation	Hiv Clinical Trials, 13(2), p. 61-69 (2012); doi:10.1310/hct1302-61	spa
dc.identifier.issn	1528-4336
dc.identifier.uri	http://hdl.handle.net/10651/6333
dc.description.statementofresponsibility	Macías, J., Neukam, K., Mallolas, J., López-Cortés, L.F., Cartón, J.A., Domingo, P., Moreno, S., Iribarren, J.A., Clotet, B., Crespo, M., De Los Santos, I., Ortega, E., Knobel, H., Jiménez-Expósito, M.J., Pineda, J.A.
dc.format.extent	p. 61-69	spa
dc.language.iso	eng
dc.relation.ispartof	Hiv Clinical Trials	spa
dc.rights	© 2012 Thomas Land Publishers
dc.source	SCOPUS	spa
dc.title	Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients	eng
dc.type	journal article
dc.identifier.local	20120670	spa
dc.identifier.doi	10.1310/hct1302-61
dc.relation.publisherversion	http://dx.doi.org/10.1310/hct1302-61	spa

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.